OraVerse is indicated for the reversal of soft-tissue anesthesia resulting from an intraoral submucosal injection of a local anesthetic containing a vasoconstrictor. OraVerse is not recommended for use in children less than 6 years of age or weighing less than 15kg (33 lbs).